Salimetrics Introduces Assay Kit for Serological Studies of Infectious Diseases
The kit consists of a test volume of 10 µL, a range of 0.39–25 ng/mL, a lower limit of detection of 0.03 ng/mL, and average inter- and intra-assay coefficients of variation less than 10%.
Salimetrics, a salivary biosciences company, announced the introduction of the new Salimetrics Total IgM Assay Kit, a testing kit that counts levels of total human IgM in saliva and other oral fluids, which can be used for sample quality assurance and as added criteria when using oral fluid as an alternative sample type for serological studies.
The kit consists of a test volume of 10 µL, a range of 0.39 – 25 ng/mL, a lower limit of detection of 0.03 ng/mL, and average inter- and intra-assay coefficients of variation less than 10%, according to a May 13, 2020 company press release. The assay is then included in a 96-well plate format for single use and is also offered in bulk packaging for high-throughput applications.
Source: Salimetrics
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
